PT - JOURNAL ARTICLE AU - Dilliott, Allison A. AU - Al Nasser, Ahmad AU - Elnageeb, Marwa AU - Fifita, Jennifer AU - Henden, Lyndal AU - Keseler, Ingrid M. AU - Lenz, Steven AU - Marriott, Heather AU - McCann, Emily AU - Mesaros, Maysen AU - Opie-Martin, Sarah AU - Owens, Emma AU - Palus, Brooke AU - Ross, Justyne AU - Wang, Zhanjun AU - White, Hannah AU - Al-Chalabi, Ammar AU - Andersen, Peter M. AU - Benatar, Michael AU - Blair, Ian AU - Cooper-Knock, Johnathan AU - Drury, Luke AU - Harrington, Elizabeth AU - Heckmann, Jeannine AU - Landers, John AU - Moreno, Cristiane AU - Nel, Melissa AU - Rampersaud, Evadnie AU - Roggenbuck, Jennifer AU - Rouleau, Guy AU - Traynor, Bryan AU - van Blitterswijk, Marka AU - van Rheenen, Wouter AU - Veldink, Jan AU - Weishaupt, Jochen AU - Harms, Matthew B. AU - Farhan, Sali M.K. AU - the Amyotrophic lateral sclerosis spectrum disorders Gene Curation Expert Panel TI - Clinical testing panels for ALS: global distribution, consistency, and challenges AID - 10.1101/2022.09.27.22280431 DP - 2022 Jan 01 TA - medRxiv PG - 2022.09.27.22280431 4099 - http://medrxiv.org/content/early/2022/09/29/2022.09.27.22280431.short 4100 - http://medrxiv.org/content/early/2022/09/29/2022.09.27.22280431.full AB - Objective In 2021, the Clinical Genome Resource (ClinGen) amyotrophic lateral sclerosis (ALS) spectrum disorders Gene Curation Expert Panel (GCEP) was established to evaluate the strength of evidence for genes previously reported to be associated with ALS. Through this endeavor, we will provide standardized guidance to laboratories on which genes should be included in clinical genetic testing panels for ALS. In this manuscript, we aimed to assess the heterogeneity in the current global landscape of clinical genetic testing for ALS.Methods We reviewed the National Institutes of Health (NIH) Genetic Testing Registry (GTR) and members of the ALS GCEP to source frequently used testing panels and compare the genes included on the tests.Results 14 clinical panels specific to ALS from 14 laboratories covered 4 to 54 genes. All panels report on ANG, SOD1, TARDBP, and VAPB; 50% included or offered the option of including C9orf72 hexanucleotide repeat expansion (HRE) analysis. Of the 91 genes included in at least one of the panels, 40 (44.0%) were included on only a single panel. We could not find a direct link to ALS in the literature for 14 (15.4%) included genes.Conclusions The variability across the surveyed clinical genetic panels is concerning due to the possibility of reduced diagnostic yields in clinical practice and risk of a missed diagnoses for patients. Our results highlight the necessity for consensus regarding the appropriateness of gene inclusions in clinical genetic ALS tests to improve its application for patients living with ALS and their families.Competing Interest StatementW.v.R. has sponsored research agreements with Biogen.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.